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Abstract Unclassified sudden infant death (USID) is the
sudden and unexpected death of an infant that remains unex-
plained after thorough case investigation including perfor-
mance of a complete autopsy and review of the circumstances
of death and the clinical history. When the infant is below
1 year of age and with onset of the fatal episode apparently
occurring during sleep, this is referred to as sudden infant
death syndrome (SIDS). USID and SIDS remain poorly un-
derstood despite the identification of several environmental
and some genetic risk factors. In this study, we investigated
genetic risk factors involved in the autonomous nervous sys-
tem in 195 Dutch USID/SIDS cases and 846 Dutch, age-
matched healthy controls. Twenty-five DNA variants from
11 genes previously implicated in the serotonin household or
in the congenital central hypoventilation syndrome, of which
some have been associated with SIDS before, were tested. Of
all DNA variants considered, only the length variation of the
polyalanine repeat in exon 3 of the PHOX2B gene was found
to be statistically significantly associated with USID/SIDS in
the Dutch population after multiple test correction. Interest-
ingly, our data suggest that contraction of the PHOX2B exon 3
polyalanine repeat that we found in six of 160 SIDS and USID
cases and in six of 814 controls serves as a probable genetic
risk factor for USID/SIDS at least in the Dutch population.
Future studies are needed to confirm this finding and to
understand the functional effect of the polyalanine repeat
length variation, in particular contraction, in exon 3 of the
PHOX2B gene.
Keywords Sudden infant death syndrome, SIDS .
Unexplained sudden infant death, USID . Congenital central
hypoventilation syndrome, CCHS . Autonomic nervous
system, ANS . Genetic association . SNPs, single nucleotide
polymorphisms . PHOX2Bpolyalanine repeat length
Electronic supplementary material The online version of this article
(doi:10.1007/s00414-013-0962-0) contains supplementary material,
which is available to authorized users.
G. Liebrechts-Akkerman : F. Liu :O. Lao :A. H. A. G. Ooms :
K. van Duijn :M. Vermeulen :M. Kayser (*)
Department of Forensic Molecular Biology, Erasmus MC University
Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam,
The Netherlands
e-mail: m.kayser@erasmusmc.nl
V. W. Jaddoe :A. Hofman
The Generation R Study Group, Erasmus MC University Medical
Center Rotterdam, Rotterdam, The Netherlands
V. W. Jaddoe :A. Hofman
Department of Epidemiology, Erasmus MC University Medical
Center Rotterdam, Rotterdam, The Netherlands
V. W. Jaddoe
Department of Paediatrics, Erasmus MC University Medical Center
Rotterdam, Rotterdam, The Netherlands
A. C. Engelberts
Department of Pediatrics, Orbis Medical Centre,
Sittard, The Netherlands
Present Address:
G. Liebrechts-Akkerman :A. H. A. G. Ooms
Department of Pathology, Erasmus MC University Medical Center
Rotterdam, Rotterdam, The Netherlands
Present Address:
K. van Duijn
Department of Statistics and Bioinformatics, Leiden University
Medical Center, Leiden, The Netherlands
Present Address:
M. Vermeulen
Department of Vaccine Generation, Crucell,
Leiden, The Netherlands
Int J Legal Med (2014) 128:621–629
DOI 10.1007/s00414-013-0962-0
Introduction
Sudden and unexpected death in infancy (SUDI) includes
every infant that dies suddenly and unexpectedly, even when
no investigations are done. If investigations, including perfor-
mance of a complete autopsy and review of the circumstances
of death and the clinical history, do not lead to a diagnosis, the
case is considered unclassified sudden infant death (USID).
Cases of sudden and unexpected death of an infant below
1 year that remain unexplained, with onset of the fatal episode
apparently occurring during sleep, are referred to as sudden
infant death syndrome (SIDS) [1]. The SIDS incidence rate in
the Netherlands is ~0.08 per 1,000 live births [2]. This value is
considerably lower than in other countries such as the USA,
where it is reported to be around 0.57 per 1,000 living births
[3]. Furthermore, given that the practised definition of SIDS in
the Netherlands comprises infant cases from birth up to 3 years
of age, the reported Dutch SIDS incidence must be considered
as over-rated. Accordingly, several cases classified in the
Netherlands as SIDS are in fact USID considering the inter-
nationally accepted definition [1]. The relatively low
USID/SIDS rate in the Netherlands might be partly explained
by the success of a parental education system that is based on
the findings of the Working Group on SIDS of the Dutch
Paediatric Society (Landelijke Werkgroep Wiegendood,
LWW).
Previous studies have identified several environmental risk
factors for SIDS, considering sleeping manners, smoking
habits of the parents, socioeconomic trades and few intrinsic
factors such as premature birth [3, 4, 5]. Notably, the physio-
logical mechanisms on how these factors contribute to SIDS
remain hypothetical. Furthermore, not all SIDS cases are, and
many healthy adults during their infancy have been, subject to
one or more of the known risk factors. Therefore, additional
environmental as well as non-environmental factors must
exist. Non-environmental factors could be of particular rele-
vance in the Dutch population, where the main environmental
factors associated to USID/SIDS are somewhat controlled due
to the LWW education program. Several genetic factors that
could explain USID/SIDS have been suggested [3, 6, 7]
are mainly from three categories: long QT syndrome, immune
system and autonomous nervous system (ANS) [3, 6, 7]. The
latter is the focus of the present study.
ANS includes genes involved in the congenital central
hypoventilation syndrome (CCHS). CCHS patients do not
react properly on elevated CO2 levels in the blood, which
may be of particular relevance in USID/SIDS since several
environmental risk factors, such as laying in the face-down
position, are expected to result in elevated CO2 levels. The
expansion of the polyalanine repeat in exon 3 of the paired-
like homeobox 2B (PHOX2B) gene is reported in 96 % of
known CCHS patients [8, 9]. Other genes have also been
associated with CCHS, such as the rearranged during
transfection (RET) gene [10–13], the glial-derived neurotroph-
ic factor (GDNF) gene [10–13], the brain-derived neurotroph-
ic factor (BDNF) gene [11], the human achaete–scute
homolog-1 (HASH1) gene [11], the paired-like homeobox-
2A (PHOX2A) gene [10–13], the endothelin-1 (EDN1) gene
[11, 13], the bone morphogenic protein-2 (BMP2) gene [13]
and the endothelin converting enzyme-1 (ECE1) gene [10, 11,
13]. All of these genes play a role in embryologic brain
development. Notably, rare DNA variants in the ECE1, RET,
PHOX2A, BMP2 and EDN1 genes have previously been
found in single SIDS cases [13].
Furthermore, ANS includes genes involved in the serotonin
household. Serotonin influences cardiovascular control, tem-
perature control, sleep–wake cycle and breathing control. The
serotonin transporter (5HTT) serves as a bottleneck in regula-
tion of serotonin release and reuptake. Previous genetic asso-
ciations of DNA polymorphisms of the 5HTT gene and its
promoter region (5HTTLPR) with SIDS have been inconclu-
sive [7], with studies reporting statistically significant associ-
ations in certain populations [14–18], but no association in
other [14, 15, 19, 20]. The latter study showed some evidence
that structural differences in the serotonergic brainstem may
contribute to the risk of SIDS [20].
Notably, most DNA variants previously found to be statis-
tically significantly associated with SIDS are rare so that large
studies are required in order to achieve statistical power.
Several environmental risk factors are suspected to trigger
SIDS through low CO2-levels, to which the ANS should
respond. Thus, the combination of such an environmental risk
factor with a genetic abnormality in one of the ANS genes
could potentially explain a subset of the SIDS cases. Because
the incidence of SIDS in the Netherlands is very low due to the
attempted control of environmental factors, the percentage of
genetic factors that underlie SIDS could be relatively enriched
in the Dutch SIDS population. We therefore studied 25 DNA
variants from 11 genes (RET, PHOX2B, PHOX2A, HASH1,
EDN1, 5HTTLPR, ECE1, GDNF, BDNF, 5HTT and BMP2)
previously involved in ANS particularly the serotonin path-
way and CCHS, in the Dutch USID/SIDS population via a
retrospective case–control study to investigate their associa-
tion with USID/SIDS using overall 195 cases and 846 healthy
age-matched controls.
Patients and methods
Study design and samples
We designed a retrospective case–control study to test for the
presence of genetic risk factors with SIDS in the Netherlands.
Details of case collection and the ethical approval have been
documented previously [5]. In summary, a total of 200
USID/SIDS cases collected across the Netherlands from
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1984 to 2005 were gathered. Of those, 167 involved infants
below 1 year of age (SIDS), whereas 33 were older (USID).
After histology review [21], cases were categorised as either
genuine USID/SIDS: no findings at histology, or (A)
USID/SIDS with incidental findings, but most likely not re-
lated to death, or (B) USID/SIDS with more extensive find-
ings that might have contributed to the demise but probably
are not a cause of death, or (C) probable cause of death. The
latter cases were excluded from the current study except for
the severe infectious cases such as bronchopneumonia be-
cause of the ongoing discussion if these can cause death on
its own or are activators of other fatal predispositions [1]. This
resulted in five cases (four SIDS and one USID) that were
excluded from the current study because of clear signs of
storage disease or fatal aspiration indicating a putative cause
of death. In the current study, we re-categorised the remaining
cases as either (1) SIDS category I according to the San Diego
criteria/USID (SIDS category I according to the San Diego
criteria; n=124), or (2) SIDS with minor infections most likely
not contributing to the demise (previously A/B, SIDS category
I according to the San Diego criteria; n=40), or (3)
USID/SIDS with incidental findings most likely not related
to death and not infectious (previously A/B, SIDS category II
according to the San Diego criteria; n=4), or (4) severe infec-
tious cases such as bronchopneumonia (previously C, SIDS
category II according to the San Diego criteria; n=14). Of 13
cases, there were too little histology slides to review [21].
Age-matched healthy infants were collected from the Gener-
ation R Study [22]. The DNAwas isolated from cord blood,
and interviews for environmental factors were taken during
pregnancy and after birth at 2, 6, 8 and 12 months of age.
Forty-eight percent was female. All controls were of Dutch
European origin. Finally, 195 cases and 846 controls all from
the Netherlands were included in this study.
Ethical approval
The project protocol was approved by the medical ethical
committees of the Erasmus MC, Rotterdam and three collab-
orating hospitals. All committees agreed that whenever the
parents had given approval for investigation into the cause of
death of their child (an autopsy), they had implicitly agreed to
participate in this study, as this study is a further investigation
into the cause of death. Because forensic paediatric autopsies
are done without parental consent, inclusion of the four foren-
sic cases in this study was done after parental approval, and
the approval of the public prosecutor or the Attorney General
involved in the respective cases was obtained.
DNA isolation
Case DNA samples were isolated from paraffin-embedded
tissue samples (see supplementary methods part 1). DNA
concentrations of case samples were estimated using the
nanodrop ND-1000 spectrometer, and the quality was tested
with an amelogenin-PCR [23]. When the amelogenin-PCR
identified gender matched the record gender information, a
PCR-based DNA quantification was carried out using the
Quantifyler Realtime PCR-kit (Applied Biosystems Inc.,
Carlsbad, CA, USA) applying the manufacturer’s protocol.
Control DNA samples from the Generation R Study were
isolated as described previously [22], were provided to this
study with a random identification number and were quanti-
DNA variants and genotyping
Twenty-two DNA variants from 11 genes (RET, PHOX2B,
PHOX2A, HASH1, EDN1, 5HTTLPR, ECE1, GDNF, BDNF,
5HTTand BMP2) were ascertained from the literature in 2006
using PubMed (www.ncbi.nlm.nih.gov) based on their
reported involvement in ANS [6, 8–16]. Furthermore, three
tagging SNPs from the exons of the RET, EDN1 and ECE1
genes were selected using the HapMap CEU data release #20
[24]. The 25 DNA variants were genotyped using various
technologies depending on marker type and technology
less the genotyping method of choice did not allow to such as
with TaqMan. For further details, see supplementary methods
2–4. The impact of expected DNA fragmentation due to
paraffin embedding of the case materials was aimed to be
minimized by designing genotyping assays targeting short
DNA fragments. Amplicon fragment length across the 25 loci
ranged between 71 and 231 bp with an average length of
117 bp. Due to expected low DNA yields from the paraffin-
embedded case samples, DNA quantity of case samples was
measured using a highly sensitive PCR-based approach. All
cases and/or controls that in the first analysis showed the
minor allele and thus influenced the statistical significance
of the association were retyped in singleplex using the same
primers as used in the multiplex analysis. Only confirmed
findings are reported.
Blinding of genotype collection and testing for DNA
contaminations
PCRs were carried out in MicroAmp optical 348 well reaction
plates (AB) containing 1 ng DNA per well of either case or
control sample. The person who ran and analysed the plates
was blinded for the case and control locations at the time of
genotyping. To control for DNA and PCR-product contami-
nation, each plate had two rows with eight wells of aquadest
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fied using PicoGreen® based on the manufacturer’s protocol.
constrains such as fluorescence-based fragment length analy-
sis, SNaPshot® single-base primer extension multiplexing
(AB), Sequenom iPLEX mass spectroscopy multiplexing
(Sequenom Inc., San Diego, CA, USA) and TaqMan® (AB)
analysis. Multiplex genotyping strategies were employed un-
representing no DNA (negative controls 1); four empty wells
to serve as negative control in the subsequent second step of
genotyping, such as SNaPshot primer extension reaction,
where they were filled with the respective reaction mix (neg-
ative controls 2); 12 DNA control samples of known geno-
types (positive controls) and eight duplicates of another plate,
to check for reproducibility between plates. The locations of
the 12 DNA controls were known to the person who ran and
analysed the plates. All plates were independently scored by
two experienced analysts. In cases where there was a discrep-
ancy between the analysts, the specific test was rerun. After all
genotypes were scored and collected, the locations of cases
and controls were released to the analyst, and statistical data
analyses were performed. Because discordance was sporadi-
cally found between the duplicates, DNA plates produced
from the same mother plates as used for producing the DNA
plates for the present study were used for genotyping of three
polymorphic miniSTR loci (D10S1248, D14S1434 and
D22S1045, see supplementary methods part 5) for contami-
nation detection. Only samples that showed no indication of
the presence of more than one individual in the miniSTR
results were finally used in the USID/SIDS marker genotype
analyses.
Statistical analyses including confounding factor
consideration
Potential deviation from the Hardy–Weinberg equilibrium
(HWE) was tested for every DNA variant used by applying
the bi-allelic chi-square test with 1 degree of freedom in
controls. As the 25 DNA variants tested are located in 11
genes, the number of independent multiple tests was set to
11. The association between each DNA variant and
USID/SIDS was examined by cross-tabulation of the case–
control status stratified by genotypes, and the Fishers exact
test was used to estimate the statistical significance of the
association. Multiple testing problem was corrected for by
using the Bonferroni method [25]. Haplotype association
was examined for all chromosomal regions by considering
sliding windows of two DNA variants using R library
haplo.stats v1.3.8 [26]. Genetic interactions between DNA
variants were tested in pair-wise fashion by comparing devi-
ances of logistic models with and without a multiplicative
interaction term. The difference in model deviances follows
chi-square distribution with 1 degree of freedom under the
null hypothesis of no interaction. Suggestive interactions were
further investigated using cross-tabulates stratified by
genotypes.
For the SIDS subjects used here for genetic analysis, prone
sleeping (odds ratio (OR)=21.3, 95 % confidence interval
(CI)=[7.4, 61.1], P<0.005), pre- and postnatal parental
smoking (smoking by both parents (OR=7.3, 95 % CI=[1.8,
30.7], P=0.006), smoking of one parent (OR=3.1, 95 %
CI=[1.1, 8.8], P=0.04)) and premature birth (OR=3.2, 95 %
CI=[1.2, 8.3], P=0.02) were previously found to be signifi-
cant environmental risk factors, while controlled for socioeco-
nomic status [5]. To exclude the potential confounding effects
of environmental and intrinsic factors on genetic association,
we repeated the multivariate logistic regression analysis with
the current case population, including USID cases and current
control group, testing for gender, prone sleeping, pre- and
postnatal parental smoking, premature birth, breastfeeding
and bed sharing. To investigate if genetic factors are specifi-
cally associated with certain USID/SIDS sub-categories that
we previously determined via histological re-examination of
the USID/SIDS subjects used here [21], we repeated the
genetic association testing for each of the four USID/SIDS
subgroups. All statistical analyses were performed using R
v2.9.2 and SPSS v20.0 (SPSS Inc, Chicago, IL, USA).
Results
AsDNA analysis from paraffin-embeddedmaterials used here
for the case samples is known to be challenging and working
with DNA plates produced via robotic means in large cohort
studies used here for the control samples may provide risks for
minor DNA contaminations, we took extra attention on assur-
ing data authenticity. Most notably, we tested for DNA con-
tamination by use of highly polymorphic miniSTR systems
(see “Patients and methods” sections and supplementary
method 5). Thirty-two case (24 SIDS and 7 USID) and 21
control samples revealed STR profiles that could not be ex-
plained by the presence of DNA from a single individual per
sample alone. As these results can be interpreted as potential
contaminations and thus could (but not necessarily will) im-
pact on the association results, we took a conservative ap-
proach and excluded these 53 samples from further analyses.
This leaves 163 cases (138 SIDS and 25 USID) and 825
healthy age-matched controls for statistical analyses. Of the
SIDS cases, 37 % were females (51 females, 86 males, one
unknown), the mean age was 140 days (approximately
4.5 months; range 17 to 338 days) and ethnicities were Euro-
pean (n=124; 89.9 %), African (n=4; 2.9 %), Arabic (n=2;
1.4 %), Asian (n=1; 0.7 %), Latin American (n=1; 0.7 %),
mixed European-African (n=3; 2.2 %), mixed European–Ar-
abic (n=1; 0.7 %), mixed European–Latin American (n=1;
0.7 %) and mixed Arabic–Latin American (n=1; 0.7 %). Of
the USID cases, 44 % were females (11 females, 14 males),
the mean age was 525 days (approximately 1 year and
5 months, range from 371 to 977 days) and ethnicities were
European (n=22, 88 %), Arabic (n=1; 4 %), Asian (n=1; 4 %)
and mixed European–Latin American (n=1; 4 %).
Next, we inspected the complete locus drop-out rates
across the 25DNAvariants tested. For the 5HTTLPR fragment
length, 57.1 % of the cases and 21.3 % of controls had no
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genotype results. We therefore excluded this DNA variant
from further analyses. The drop-out rates for the remaining
24 DNA variants considering the 163 case samples after
quality control ranged from 0 % for 12 loci (RET P1039L,
RET R114H, RET L56M, RET G691S, RET D489N, BDNF
rs8192466, GDNF R93W, EDN1 rs1476046, 5HTT
rs2020939, PHOX2B 618ins, ECE1 rs1076669 and BMP2
L292F) to 4.3 % for RET T706A and ECE1 rs6665399 with
an average drop-out rate for the cases across all 24 loci of
1.04 % (supplementary table 3). Drop-out rates for control
samples were found to be lower with an average rate across all
24 loci of 0.34 % and a range from 0 % for 13 loci (RET
P1039L, RETR114H, RETR418Q, RETG691S, RETD489N,
BDNF rs8192466, GDNF R93W, EDN1 rs5370, 5HTT
rs2020939, PHOX2B 618ins, ECE1 rs1076669, ECE1
T354A and BMP2 L292F) to 2.3 % for BMP2 rs2273073
(supplementary table 3). All 24 DNA variants considered
followed HWE (P>0.05) in the controls, and no genetic
interactions were found among DNA variants of different
genes.
Of the 24 DNAvariants tested, only the polyalanine repeat
length variation in exon 3 of the PHOX2B gene was found to
be statistically significantly associated with USID/SIDS in the
tested Dutch samples (Table 1; for non-significant variants,
see Table 2). The normal length of the PHOX2B polyalanine
repeat as established with the method used was 112 bp
(representing 20 alanine repeats), and most cases and controls
(98.3 %) were found to be homozygous for this normal length
allele. However, contractions of the alanine repeat array (vary-
ing from 3 bp or one alanine to 12 bp or four alanines) were
statistically significantly more often found in USID/SIDS
cases compared to healthy age-matched controls (OR=6.05,
95 % CI=[2.02, 18.1], P<0.001). Notably, the USID/SIDS
association effect of the contracted repeat remained statistical-
ly significant after Bonferroni multiple test correction. This
effect was also seen at the homozygote stage of the contracted
allele (OR=infinitive, P<0.001), albeit only with one SIDS
case sample (no USID case, hence one in 160 cases in total)
with a contraction of three repeats (9 bp or three alanines) in
both alleles, while none of the 814 control samples showed the
homozygote stage of this repeat contraction. Repeat expan-
sions (varying from 3 bp or one alanine to 15 bp or five
alanines) also occurred in our case and control samples. A
statistically significant USID/SIDS association of the expand-
ed allele was only seen for the homozygote stage (OR=
infinitive; P<0.001) also after multiple test correction. This
effect was caused by a single control sample (both alleles
expanded by 12 bp or four alanines). However, when consid-
ering the presence of at least one expanded allele, no statisti-
cally significant USID/SIDS effect of the expanded repeat was
seen (OR=1.27, 95 % CI=[0.14, 11.4], P=0.83). The geno-
type combination of one expanded and one contracted allele
present within the same individual was not found among the
case and control samples tested, which may simply be a
sample size effect or may have an underlying unknown bio-
logical reason. Noteworthy, three of the six cases that carried
repeat contractions were older than 1 year and therefore fall
under the USID definition, while the other three cases were
under 1 year of age and classified as SIDS category I accord-
ing to the San Diego criteria. If one applies the <1-year
definition of SIDS to the cases and controls used in this study,
the association of the PHOX2B exon 3 repeat contraction
remains significantly associated for the homozygous state
(OR not applicable/infinitive and P<0.001) and the <112
allele frequency (OR=3.97, 95 % CI=[1.1–14.17], P=
0.034). The heterozygous state is not statistically significantly
SIDS associated any longer (OR=1.97, 95 % CI=[0.39–
9.87], P=0.33), which could be due to lack of statistical
power. However, the heterozygous state remains significantly
associated with the USID cases considering the <3-year age
criterion (OR=18.4, 95 % CI=[4.32–78.38], P<0.001), as
does the <112 allele frequency (OR=17.24, 95 %
CI=[4.19–71.04], P<0.001).
All six SIDS/USID cases with the PHOX2B polyalanine
repeat contraction were of Dutch European bio-geographic
origin as reported by the parents during interviews, and their
USID/SIDS status was previously categorised based on his-
tology re-review as SIDS category I according to the San
Table 1 Evidence for statistically
significant USID/SIDS associa-
tion of the PHOX2B exon 3
polyalanine repeat in the Dutch
population considering a total of
163 cases and 825 healthy
age-matched controls
a Fisher exact test for association
Genotypes
(bp)
# Cases # Controls OR 95 % CI P value
Low High
112/112 153 805
<112/<112 1 0 Not applicable (infinitive) <0.001a
112/<112 5 6 43.5 13.11 282.9 <0.001
Alleles <112 7 6 6.05 2.02 18.1 <0.001
>112/>112 0 1 Not applicable (infinitive) <0.001a
112/>112 1 2 1.004 0.05 37.8 1.0
Alleles>112 1 4 1.27 0.14 11.4 0.83
Dropouts 3 11
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Diego criteria/USID (cases with no pathological findings
whatsoever) or SIDS/USID with signs of minor infection [21]
(for further case description, see Table 3 and supplementary
material 6).
Data on the environmental factors that are involved in some
of cases used here have been published before [5]. Although
in that previous study [5] a different control group was applied
and only the cases under 1 year of age were used, similar
results are obtained when testing the complete SIDS/USID
case group as used here and the control group as used here for
which environmental data were also available to us. Smoking
by both parents (OR=129.8, 95 % CI=[23.6, 715.1],
P<0.0005), smoking of one parent (OR=13.4, 95 %
CI=[5.2, 34.4], P<0.005) and prone sleeping (OR=39.6,
95 % CI=[15.6, 100.9], P<0.005) were all identified as sta-
tistically significant environmental risk factors for
USID/SIDS when controlled for socioeconomic status. Pre-
term birth did not reach statistical significance (OR=2.6, 95%
CI=[0.8, 8.4], P=0.11]) in contrast to our previous study [5].
However, none of the highlighted statistically significant
environmental risk factors showed up as statistically signifi-
cantly associated confounding factors for the PHOX2B exon 3
alanine repeat contraction. No association was found between
any of the 24 tested DNA variants and any of the four
USID/SIDS sub-category as previously determined by histo-
logical re-evaluation [21] (data not shown).
Discussion
Our study provides evidence for USID/SIDS association of
the PHOX2B gene in the Dutch population. The PHOX2B
polyalanine repeat had not been associated with SIDS in
previous studies, although expansion of its exon 3 polyalanine
repeat had been identified in a large proportion of CCHS
patients [7–9]. In fact, the PHOX2B exon 3 polyalanine repeat
expansion was described as characteristic genetic element of
CCHS [7–9] and additionally has been proven causative in a
mouse model [27]. Here, we found one SIDS category I
according to the San Diego criteria case with one allele
Table 2 Results for DNA variants tested without finding statistically significant USID/SIDS association in the Dutch population studied
Gene RS
number
Nucleotide
change
Amino acid
change
Chromosome Position Controls Cases P value
USID/SIDS
associationAA AB BB AA AB BB
ECE1 rs6665399 C8234021T Intron region 1 21426520 167 414 241 33 74 49 0.84
ECE1 rs1076669 C1022T T341I 1 21446404 686 135 3 139 24 0 0.47
ECE1 A1060G T354A 1 21446441 824 0 0 163 0 0 –
PHOX2B 618/619insC 722–
759del37nt
4 41442961 824 0 0 163 0 0 –
GDNF C277T R93W 5 37851912 811 13 0 161 2 0 0.74
EDN1 rs1476046 G7639A Intron region 6 12401207 43 295 482 2 74 87 0.78
EDN1 rs5370 G594T K198N 6 12404241 512 271 41 102 56 3 0.38
RET G35A R12H 10 42892747 814 0 0 162 0 0 –
RET C166A L56M 10 42916005 815 7 0 160 3 0 0.25
RET C1157T A386V 10 42924578 822 0 0 161 0 0 –
RET G1253A R418Q 10 42924674 814 10 0 162 0 0 0.16
RET G1463A D489N 10 42926862 822 1 1 163 0 0 0.55
RET rs1799939 G2071A G691S 10 42930125 570 233 21 112 48 3 0.96
RET A2116G T706A 10 42932086 823 0 0 156 0 0 –
RET C3116T P1039L 10 42942105 822 1 1 161 2 0 0.23
RET G341A R114H 10 42917799 824 0 0 163 0 0 –
BDNF C289T I2T 11 27636715 807 17 0 161 2 0 0.48
HTT rs2020939 C17223T Intron region 17 25574858 233 423 168 49 81 33 0.75
BMP2 rs2273037 T570A S190R 20 6698882 775 29 1 152 6 0 0.97
BMP2 rs235768 T109G S37A 20 6707115 280 401 142 53 86 23 0.77
BMP2 C874T L292F 20 6707419 824 0 0 163 0 0 –
PHOX2A C287A T96K 11 71629959 819 0 0 162 0 0 –
Allele frequency 155/158 <155 >158 155/158 <155 >158 >158=0.32
HASH1 108–131del A36–A43 12 1,547 21 62 307 6 9 <155=0.42
A common allele, B rare allele
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expanded (by one repeat) but also noted repeat expansions
among three healthy controls, two with one allele expanded
(one repeat and five repeats, respectively) and one with both
alleles expanded (by four repeats). Although we did find a
statistically significant association with USID/SIDS when the
expanded allele occurred in the homozygous stage, no asso-
ciation was seen when considering both homozygote and
heterozygote carriers of the expanded allele together. Because
the significant finding came from one homozygous control
individual only and carrying only one copy of the expanded
allele did not provide any USID/SIDS association, it is diffi-
cult to conclude based on our current data whether the repeat
expansion is involved in USID/SIDS and more data are
needed.
However, our study provides evidence for a statistically
significant USID/SIDS association with the contraction of the
PHOX2B exon 3 polyalanine repeat, which remained signifi-
cant after correction for multiple testing. As with the expanded
allele, we also see for the contracted allele a significant SIDS
association in the homozygote stage (again only one sample,
but a case instead of a control sample as for the expanded
repeat). However, in contrast to the repeat expansion, we see a
statistically significant USID/SIDS association when consid-
ering homo- and heterozygote carriers of the contracted allele
together. This provides more convincing evidence for
USID/SIDS involvement of the repeat contraction than what
we obtained for the repeat expansion. Exon 3 polyalanine
repeat contractions have previously been found in healthy
control populations of CCHS and SIDS studies, but not in
SIDS cases [9, 10, 13, 28–30]. A recent study by Jennings
et al. [31] reports four phenotypic CCHS cases that were all
negative for the PHOX2B polyalanine repeat expansion but
had heterogenic deletion in or of the PHOX2B gene, all
including exon 3 where the polyalanine repeat is locat-
ed. No CCHS case or control individual has been pre-
viously reported carrying both alleles in the contracted
repeat length fashion, such as one of the USID/SIDS cases
observed here.
Notably, PHOX2B knockout mice have been made, but
homozygous knockouts were never born alive, while hetero-
zygous knockouts had an altered response to hypoxia and
hypercapnia at birth resulting in longer posthypoxic apnoeas
that recovered during maturity [32]. Furthermore, relative to
normal PHOX2B+/+ mice, these PHOX2B−/+ mice had a
longer apnoea time during regular sleep, while during the
wake period there was no breathing difference [33]. Further-
more, birth weight of PHOX2B−/+ mice was reported to be
lower than that of their PHOX2B+/+ siblings [33]. These
findings in mice are in line with our results of the association
betweenUSID/SIDS and the contraction of the PHOX2Bexon
3 polyalanine repeat. By definition SIDS occurs during sleep
[1], and one of the risk factors is low birth weight [3]. Fur-
thermore, many USID/SIDS cases are reported with a proba-
ble internal or external cause of hypoxia, and many of the
well-known risk factors can be linked with breathing such as
prone sleeping [3–5], soft bedding [3], parental smoking [3, 5]
and minor infection [3, 6, 21]. Four out of the six USID/SIDS
cases for which we identified PHOX2B exon 3 repeat contrac-
tions had one or more of these environmental risk factors
(Table 2). Furthermore, Lavezzi et al. [28] found a decreased
amount of neurons that stained positively with PHOX2B
immunohistochemistry in the retrotrapezoid nucleus in the
medulla oblongata in 12 out of 22 SIDS cases (55 %) com-
pared to none out of 11 age-matched deceased controls. This
finding corresponds to a hypoplastic retrotrapezoid nucleus
that is toughed to be responsible for the “drive to breath” [28].
All the cases tested in their studies had a normal 20/20
PHOX2B polyalanine repeat, but they did hypothesise that
part of the SIDS cases are due to an unknown PHOX2B
mutation or mutation in the PHOX2B pathway. Other studies
have also associated the PHOX2B gene to SIDS; Rand et al.
[29] did previously find an association between Caucasian
American SIDS cases and a common polymorphism in intron
2 (IVS2+101>G; g.1364A>G) of the PHOX2B gene; there
was no association in African American SIDS cases since the
incidence of this polymorphism is very high in African
Table 3 Particulars of Dutch USID/SIDS cases carrying the contracted allele of the PHOX2B exon 3 polyalanine repeat
Contracted
PHOX2B alleles
Sex Age
(days)
Pregnancy Sleeping
position
Parental smoking Microbiology Autopsy
Both Male 140 Dizygotic twin,
3,600 g at birth
Supine No Negative No abnormalities
One Female 18 Unremarkable Supine Maternal pre- and postnatal Negative No abnormalities
One Male 126 Unremarkable Supine Maternal pre- and postnatal Echovirus 18 Laryngitis
One Male 405 Unremarkable Prone Paternal and maternal
pre- and postnatal
Negative Tonsillitis and laryngitis
One Female 545 Dizygotic twin,
2,010 g at birth
Prone Maternal postnatal Staphylococcus aureus
in nose and throat
No abnormalities
One Male 977 Unremarkable Supine No Negative Meckel’s diverticulum with
ectopic pancreatic tissue
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Americans (frequency of the G allele was 0.52 in the matched
controls) [29].
Besides PHOX2B, no DNA variant from any other gene
investigated here showed statistically significant association
with USID/SIDS in our dataset. Previous studies carried out in
other populations found SIDS associations for ten of the 24
DNA variants tested here in the Dutch population (i.e. 5HTT
rs202939, RETR12H, RET L56M, RETA386V, RETR418Q,
RETG691S, EDN1 rs5370, PHOX2AT96K, ECE1 rs1076669
and BMP2 rs235768) [13, 14]. That none of these DNA
variants revealed a statically significant association with
USID/SIDS in our study may be explained by the rare variant
nature of these DNA polymorphisms, perhaps in combination
with population effects. Previously reported SIDS associa-
tions for all these genetic loci were caused by single individual
findings only [13, 14].
This study is not without caveats. Firstly, autopsy material
is usually not prepared and handled in DNA-free environment
so that DNA contamination can potentially occur at this level
already. Secondly, DNA fragmentation during paraffin em-
bedding, release and/or autolysis of the tissue prior to collec-
tion causes low DNAyields, which can lead to increased risk
of detecting minor DNA contaminations and to allelic or
complete locus dropout [34]. Therefore, using paraffin-
embedded materials as DNA source causes problems in ge-
netic analysis such as the high dropout rates and contamina-
tion encountered in this study. Using robotics for extracting
and handling DNA samples in large cohort studies, such as
used here for the control samples, is not free of risk, either as it
potentially can introduce minor DNA contamination. A con-
servative approach towards data cleaning was taken by ex-
cluding all samples that showed even the smallest signs of
potential DNA contamination during highly sensitive
miniSTR profiling without testing and knowing if such effects
would impact on the genetic associations and by excluding
5HTTLPR because of an usually high drop-out rate. By doing
so, the statistical power to detect statistically significant ge-
netic associations was reduced, and the risk of false negative
findings was increased. The very high dropout of the
5HTTLPR fragment length analysis might be explained by
the large number of repeats in the sequence and the large
amounts of guanine and cytosine, although a 70 % GC nucle-
otide mixture was used. To control for the difference in DNA
quantity and quality between the paraffin-extracted case DNA
and cord blood-extracted control DNA, a PCR-based DNA
quantificationmethod was used for the cases, and PCR primers
were designed for short amplicons (see supplementary method
sections 2 and 3 for details).
In conclusion, of the 24 DNAvariants tested from 11 genes
involved in the autonomous nervous system, only the length
variation of the polyalanine repeat in exon 3 of the PHOX2B
gene was found to be statistically significantly associated with
USID/SIDS in the Dutch population after multiple test
correction. Our data enforce the previous hypothesis that there
is an association between PHOX2B and SIDS and suggest that
contractions of the PHOX2B exon 3 polyalanine repeat prob-
ably serve as genetic risk factor for USID/SIDS at least in the
Dutch population. Future studies and larger study populations
are needed to confirm this and to understand the functional
effect of the polyalanine repeat length variation, in particular
its contraction, in exon 3 of the PHOX2B gene.
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